Neuroendocrine and Adrenal Tumors (NETAT)

University of Pennsylvania

Status: Withdrawn

Conditions: Adrenal Tumor; Neuroendocrine Tumors

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04432532

832475

Details and patient eligibility

About

This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in conjunction with IRB#831990 which is a retrospective protocol. The University of Pennsylvania will be a contributing site with the University of Michigan as the coordinating site for the A5 alliance, a multi-institutional collaborative designed to study neuroendocrine and adrenal tumors.

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosed with neuroendocrine and/or an adrenal tumor

Exclusion criteria

• pregnant women
• prisoners
• people under the age of 18

Trial design

0 participants in 2 patient groups

Neuroendocrine Tumor

Treatment:

Other: No intervention

Adrenal Tumor

Treatment:

Other: No intervention